, Biogen Idec's former EVP of Corporate and Business Development, was appointed as EVP of Corporate Development and Strategy and General Counsel at 

 (Research Triangle Park, NC), a global provider of contract development and manufacturing services to the global pharmaceutical industry.

(Research Triangle Park, NC) has appointed 

as the newest addition to the senior management team as Director, Quality Management.

• Bringing with him more than 25 years of experience in all operational aspects of clinical trial planning, execution, and delivery, 

(Philadelphia, PA) Vice President, Biostatistics and Data Operations for North America.

 as Vice President and General Manager of ICON's Bioanalytical Operations in Manchester, UK. 

(Rome, Italy) has elected a new executive board for a two-year term and includes 

 (College-viille, PA) Head of Clinical Innovation where he will work across Development Operations' stakeholders to help define Pfizer's vision for the future of clinical trials. 

(Craigavon, Northern Ireland) Clinical Technologies business unit announced that 

has joined the company as Vice President of Clinical Project Services and as a member of the Executive Leadership Team where he will oversee clinical project management and drug supply services globally. 

 was selected as Chief Executive Officer for 

 (London, UK). Barba will remain the Chairman of the Marken Board of Directors. 

 as Executive Vice President, Global Business Development. 

 as Vice President, International Projects.   

 (Princeton, NJ) has strengthened its leadership team with the addition of two new executives including 

 as Executive Vice President of Supply Chain Business, and 

 (Plymouth Meeting, PA) as Chief Operating Officer. In this role, Larson will be responsible for global operations and lead the client services, logistics and help desk functions.   

• With over 14 years of experience in developing and directing a variety of drug and device development programs, 

(Cary, NC) Pre-Clinical and Regulatory Affairs group within the OckhamCRO division. 

(Dublin, Ireland) has formed a strategic alliance with 

 (BCRI) (Boston, MA) that will combine BCRI's leadership in clinical strategy, study planning, and academic relationships with ICON's experience in the execution of global clinical trials.

(Fremont, CA) has entered into an agreement with 

The University of Texas MD Anderson Cancer Center

 (Houston, TX) where the center will use Velos eResearch for its clinical studies.

(Durham, NC) strategic development division for a global female contraceptive study that will involve 60 sites and 2,800 patients. 

 (London, UK) as a Medidata Technology Partner. 

At the 2011 Association of Clinical Research Professionals (ACRP) Annual Awards, 

 (Seattle, WA) awarded the Outstanding Leadership in Clinical Research Leadership as a Clinical Research Coordinator to 

, Clinical Research Coordinator for Emergency Medicine at 

Louisiana State University Health Sciences Center 

(Shreveport, LA), the Leadership as a Clinical Research Associate award to 

, ACRP Credentialed Trainer, Clinical Research Consultant, and GCP Trainer with 

(Burnsville, MN), and the Leadership as a Project Manager award to 

 (Dubai, United Arab Emirates). In addition, 

, Chief Executive Officer and Founder of 

(Westborough, MA) won the Innovation in Clinical Research Award, and 

, Program Director and Clinical Trials Research Associate with the 

 (Durham, NC), was awarded the Advancing Awareness in Clinical Research award. 

, former Chair of the ACRP Association Board of Trustees, posthumously won the Chairperson's Award.

 (Chicago, IL) has been included in the list of "Cool Vendors" in the "Cool Vendors in Life Sciences, 2011" report by Gartner, Inc.

(Durham, NC) has created a strategic development division that aligns the interests of pharmaceutical companies, medical device companies, physicians, and patients with a risk sharing model that accelerates clinical development through incentive-based performance and fixed-price investments. 

 (Charlottsville, VA) announced that its EU affiliate has been awarded a prestigious grant worth $500,000 for research and development in the area of personalized medicine. 

(Minneapolis, MN) announced its Health Economics and Outcomes Research services. DCR's Health Economics and Outcomes Research services include strategic consulting, economic modeling, epidemiology, biostatistics, prospective study design, execution, analysis, disease management design, execution, and evaluation, among others.

 (Cary, NC) has recently published a customer success story that features the extensive history between the two companies working alongside each other to accelerate clinical trials with clean, on-time data.

(Cincinnati, OH) jointly announced a definitive merger agreement under which INC Research will acquire Kendle in an all-cash transaction with a total equity value of approximately $232 million. 

 (PFC) (Zurich, Switzerland) jointly announced a definitive merger agreement under which Clinipace Worldwide has acquired all outstanding shares of privately-held PFC and its subsidiaries.  

News

Applied Clinical Trials-07-01-2011

Industry news focusing on the people and organizations who work in the clinical trials profession.